Skip to main content

Table 1 Correlation between MACC1-AS1, MACC1 and clinicopathological parameters

From: The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1

n (%)

MACC1-AS1

MACC1

Low and negative (n)

High (n)

P

Low and Negative (n)

High (n)

P

Age (years)

  

0.752

  

0.803

 ≥55

72(58.5%)

43

29

 

45

27

 

 <55

51(41.5%)

29

22

 

33

18

 

Sex

   

0.351

   

 Male

76(61.8%)

42

34

 

45

31

0.22

 Female

47(38.2%)

30

17

 

33

14

 

TNM stage

  

0.022*

  

0.002**

 I

17(13.8%)

15

2

 

14

3

 

 II

25(20.3%)

14

11

 

19

6

 

 III

43(35.0%)

25

18

 

28

15

 

 IV

38(30.9%)

18

20

 

17

21

 

Tumor invasion

  

0.024*

  

0.135

 T1

12(9.8%)

10

2

 

9

3

 

 T2

14(11.4%)

10

4

 

11

3

 

 T3

50(40.7%)

29

21

 

31

19

 

 T4

47(38.2%)

23

24

 

27

20

 

Lymph node metastasis

  

0.004**

  

0.034*

 N0

29(23.6%)

22

7

 

13

13

 

 N1

34(27.7%)

20

14

 

20

14

 

 N2

34(27.7%)

22

12

 

23

11

 

 N3

26(21.1%)

8

18

 

22

7

 

Distant metastasis

  

0.065

  

0.055

 M0

101(82.1%)

63

38

 

68

33

 

 M1

22(17.9%)

9

13

 

10

12

 

Tumor differentiation

  

0.963

  

0.923

 Well

6(4.9%)

5

1

 

5

1

 

 Moderate

20(16.3%)

10

10

 

11

9

 

 Poor

97(78.9%)

57

40

 

62

35

 

Mortality

  

0.213

  

0.138

 Survive

13(34.2%)

8

5

 

8

5

 

 die

25(65.8%)

10

15

 

9

16

 

Recurrence

  

0.012*

  

0.114

 No

40(47.1%)

31

9

 

32

8

 

 Yes

45(52.9%)

23

22

 

29

16

 
  1. *P<0.05; **P<0.01
Back to article page

Molecular Cancer

ISSN: 1476-4598